First Tracks Biotherapeutics Inc (TRAX) Stock Ticker
TRAX right now
Market factors today
Unlock the full TRAX picture
About First Tracks Biotherapeutics Inc
First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.
TRAX stock facts
| Ticker symbol | TRAX |
| Exchange | NASDAQ Global Select |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $1.2B |
| CEO | Daniel R. Faga |
| Employees | 104 |
| Headquarters | San Diego, CA, US |
| IPO date | 2026-04-20 |
| Website | www.firsttracksbio.com |
What you can see for TRAX on Tickr
Live TRAX price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the TRAX report.
Rankings
FAQ
What is the ticker symbol for First Tracks Biotherapeutics Inc?
The ticker symbol for First Tracks Biotherapeutics Inc is TRAX, listed on the NASDAQ Global Select.
What is TRAX?
First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.